FDA Inspection 1265444 - BioEclipse Therapeutics, Inc. - March 25, 2025

Record Details

This FDA Inspection record concerns BioEclipse Therapeutics, Inc., with an inspection on March 25, 2025, issued by the San Francisco District Office, covering biologics.

Company: BioEclipse Therapeutics, Inc.
Inspection Date: March 25, 2025
Product Type: Biologics
Office: San Francisco District Office

Open in Dashboard

ID · dc212f11-2dc0-4d60-835a-d37928abaaa0

Violation Codes1

21 CFR 312.50

Full citation text and observation details available on the Dashboard.